![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SIRT6 |
Gene summary for SIRT6 |
![]() |
Gene information | Species | Human | Gene symbol | SIRT6 | Gene ID | 51548 |
Gene name | sirtuin 6 | |
Gene Alias | SIR2L6 | |
Cytomap | 19p13.3 | |
Gene Type | protein-coding | GO ID | GO:0000018 | UniProtAcc | Q8N6T7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51548 | SIRT6 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.24e-14 | 5.57e-01 | -0.1808 |
51548 | SIRT6 | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.52e-03 | 3.31e-01 | -0.1207 |
51548 | SIRT6 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.78e-04 | 3.44e-01 | -0.1464 |
51548 | SIRT6 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.60e-02 | 2.35e-01 | -0.059 |
51548 | SIRT6 | LZE4T | Human | Esophagus | ESCC | 3.93e-05 | 1.43e-01 | 0.0811 |
51548 | SIRT6 | LZE7T | Human | Esophagus | ESCC | 1.32e-06 | 3.05e-01 | 0.0667 |
51548 | SIRT6 | LZE8T | Human | Esophagus | ESCC | 1.29e-04 | 1.82e-01 | 0.067 |
51548 | SIRT6 | LZE20T | Human | Esophagus | ESCC | 4.56e-08 | 1.46e-01 | 0.0662 |
51548 | SIRT6 | LZE22T | Human | Esophagus | ESCC | 3.34e-02 | 2.51e-01 | 0.068 |
51548 | SIRT6 | LZE24T | Human | Esophagus | ESCC | 7.12e-09 | 2.23e-01 | 0.0596 |
51548 | SIRT6 | LZE21T | Human | Esophagus | ESCC | 1.34e-04 | 2.25e-01 | 0.0655 |
51548 | SIRT6 | LZE6T | Human | Esophagus | ESCC | 5.08e-05 | 2.52e-01 | 0.0845 |
51548 | SIRT6 | P1T-E | Human | Esophagus | ESCC | 5.05e-08 | 2.48e-01 | 0.0875 |
51548 | SIRT6 | P2T-E | Human | Esophagus | ESCC | 1.30e-15 | 2.52e-01 | 0.1177 |
51548 | SIRT6 | P4T-E | Human | Esophagus | ESCC | 1.37e-18 | 3.52e-01 | 0.1323 |
51548 | SIRT6 | P5T-E | Human | Esophagus | ESCC | 1.13e-08 | 1.87e-01 | 0.1327 |
51548 | SIRT6 | P8T-E | Human | Esophagus | ESCC | 2.28e-35 | 5.94e-01 | 0.0889 |
51548 | SIRT6 | P9T-E | Human | Esophagus | ESCC | 8.65e-21 | 3.56e-01 | 0.1131 |
51548 | SIRT6 | P10T-E | Human | Esophagus | ESCC | 1.01e-32 | 4.74e-01 | 0.116 |
51548 | SIRT6 | P11T-E | Human | Esophagus | ESCC | 4.89e-11 | 3.99e-01 | 0.1426 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00147067 | Oral cavity | OSCC | striated muscle tissue development | 174/7305 | 384/18723 | 6.45e-03 | 2.40e-02 | 174 |
GO:00605629 | Oral cavity | OSCC | epithelial tube morphogenesis | 149/7305 | 325/18723 | 6.73e-03 | 2.50e-02 | 149 |
GO:01061065 | Oral cavity | OSCC | cold-induced thermogenesis | 71/7305 | 144/18723 | 7.51e-03 | 2.75e-02 | 71 |
GO:01201615 | Oral cavity | OSCC | regulation of cold-induced thermogenesis | 71/7305 | 144/18723 | 7.51e-03 | 2.75e-02 | 71 |
GO:00016594 | Oral cavity | OSCC | temperature homeostasis | 84/7305 | 174/18723 | 7.84e-03 | 2.87e-02 | 84 |
GO:19908454 | Oral cavity | OSCC | adaptive thermogenesis | 76/7305 | 157/18723 | 1.02e-02 | 3.52e-02 | 76 |
GO:0010498110 | Oral cavity | LP | proteasomal protein catabolic process | 224/4623 | 490/18723 | 9.57e-25 | 4.00e-22 | 224 |
GO:0043161110 | Oral cavity | LP | proteasome-mediated ubiquitin-dependent protein catabolic process | 190/4623 | 412/18723 | 1.08e-21 | 2.93e-19 | 190 |
GO:0042176110 | Oral cavity | LP | regulation of protein catabolic process | 177/4623 | 391/18723 | 3.00e-19 | 5.87e-17 | 177 |
GO:0045862110 | Oral cavity | LP | positive regulation of proteolysis | 165/4623 | 372/18723 | 5.40e-17 | 8.46e-15 | 165 |
GO:1903362110 | Oral cavity | LP | regulation of cellular protein catabolic process | 119/4623 | 255/18723 | 1.52e-14 | 1.76e-12 | 119 |
GO:1903050110 | Oral cavity | LP | regulation of proteolysis involved in cellular protein catabolic process | 101/4623 | 221/18723 | 7.00e-12 | 5.48e-10 | 101 |
GO:0061136110 | Oral cavity | LP | regulation of proteasomal protein catabolic process | 89/4623 | 187/18723 | 8.05e-12 | 6.15e-10 | 89 |
GO:0009896110 | Oral cavity | LP | positive regulation of catabolic process | 187/4623 | 492/18723 | 2.30e-11 | 1.58e-09 | 187 |
GO:0045732110 | Oral cavity | LP | positive regulation of protein catabolic process | 103/4623 | 231/18723 | 2.68e-11 | 1.81e-09 | 103 |
GO:0032434110 | Oral cavity | LP | regulation of proteasomal ubiquitin-dependent protein catabolic process | 67/4623 | 134/18723 | 2.09e-10 | 1.13e-08 | 67 |
GO:0031331110 | Oral cavity | LP | positive regulation of cellular catabolic process | 163/4623 | 427/18723 | 3.03e-10 | 1.59e-08 | 163 |
GO:2000058110 | Oral cavity | LP | regulation of ubiquitin-dependent protein catabolic process | 77/4623 | 164/18723 | 4.50e-10 | 2.22e-08 | 77 |
GO:1903364110 | Oral cavity | LP | positive regulation of cellular protein catabolic process | 72/4623 | 155/18723 | 2.93e-09 | 1.28e-07 | 72 |
GO:190180019 | Oral cavity | LP | positive regulation of proteasomal protein catabolic process | 57/4623 | 114/18723 | 4.56e-09 | 1.91e-07 | 57 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04714 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa05230 | Colorectum | AD | Central carbon metabolism in cancer | 33/2092 | 70/8465 | 3.61e-05 | 3.19e-04 | 2.03e-04 | 33 |
hsa047141 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa052301 | Colorectum | AD | Central carbon metabolism in cancer | 33/2092 | 70/8465 | 3.61e-05 | 3.19e-04 | 2.03e-04 | 33 |
hsa047142 | Colorectum | SER | Thermogenesis | 106/1580 | 232/8465 | 1.15e-21 | 6.34e-20 | 4.61e-20 | 106 |
hsa052302 | Colorectum | SER | Central carbon metabolism in cancer | 25/1580 | 70/8465 | 5.43e-04 | 4.51e-03 | 3.27e-03 | 25 |
hsa047143 | Colorectum | SER | Thermogenesis | 106/1580 | 232/8465 | 1.15e-21 | 6.34e-20 | 4.61e-20 | 106 |
hsa052303 | Colorectum | SER | Central carbon metabolism in cancer | 25/1580 | 70/8465 | 5.43e-04 | 4.51e-03 | 3.27e-03 | 25 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0523018 | Esophagus | ESCC | Central carbon metabolism in cancer | 50/4205 | 70/8465 | 1.70e-04 | 6.62e-04 | 3.39e-04 | 50 |
hsa04714310 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0523019 | Esophagus | ESCC | Central carbon metabolism in cancer | 50/4205 | 70/8465 | 1.70e-04 | 6.62e-04 | 3.39e-04 | 50 |
hsa0471430 | Oral cavity | OSCC | Thermogenesis | 138/3704 | 232/8465 | 7.67e-07 | 4.35e-06 | 2.22e-06 | 138 |
hsa0523016 | Oral cavity | OSCC | Central carbon metabolism in cancer | 49/3704 | 70/8465 | 7.57e-06 | 3.59e-05 | 1.83e-05 | 49 |
hsa04714113 | Oral cavity | OSCC | Thermogenesis | 138/3704 | 232/8465 | 7.67e-07 | 4.35e-06 | 2.22e-06 | 138 |
hsa0523017 | Oral cavity | OSCC | Central carbon metabolism in cancer | 49/3704 | 70/8465 | 7.57e-06 | 3.59e-05 | 1.83e-05 | 49 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SIRT6 | SNV | Missense_Mutation | rs540970217 | c.583C>T | p.Arg195Trp | p.R195W | Q8N6T7 | protein_coding | deleterious(0) | benign(0.344) | TCGA-BH-A203-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
SIRT6 | deletion | Frame_Shift_Del | novel | c.193delN | p.Arg65GlyfsTer95 | p.R65Gfs*95 | Q8N6T7 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
SIRT6 | deletion | Frame_Shift_Del | c.671delN | p.Asn224ThrfsTer39 | p.N224Tfs*39 | Q8N6T7 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | |||
SIRT6 | SNV | Missense_Mutation | c.787N>C | p.Thr263Pro | p.T263P | Q8N6T7 | protein_coding | tolerated(0.09) | benign(0.046) | TCGA-C5-A1BF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
SIRT6 | SNV | Missense_Mutation | c.956N>T | p.Pro319Leu | p.P319L | Q8N6T7 | protein_coding | deleterious(0) | benign(0.133) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD | |
SIRT6 | SNV | Missense_Mutation | c.806N>A | p.Leu269Gln | p.L269Q | Q8N6T7 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SIRT6 | SNV | Missense_Mutation | c.94N>T | p.Arg32Trp | p.R32W | Q8N6T7 | protein_coding | deleterious(0.02) | possibly_damaging(0.466) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SIRT6 | SNV | Missense_Mutation | novel | c.908N>A | p.Ser303Tyr | p.S303Y | Q8N6T7 | protein_coding | tolerated(0.05) | benign(0.085) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SIRT6 | SNV | Missense_Mutation | novel | c.1055N>T | p.Ala352Val | p.A352V | Q8N6T7 | protein_coding | tolerated_low_confidence(0.33) | benign(0) | TCGA-AX-A0IZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SIRT6 | SNV | Missense_Mutation | novel | c.653N>G | p.Gln218Arg | p.Q218R | Q8N6T7 | protein_coding | deleterious(0) | benign(0.327) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
51548 | SIRT6 | TRANSCRIPTION FACTOR, ENZYME | inhibitor | 252827474 | ||
51548 | SIRT6 | TRANSCRIPTION FACTOR, ENZYME | allosteric modulator | 381118833 |
Page: 1 |